Dr Naresh Jadhav, Dr Rani Lakhe, Dr Sunil Sahasrabuddhe, Mahesh Nangia, Dr A K Gunju and Dr Vaibhav Sonwane at the press conference on Monday.
AMERICAN Oncology Institute, Nagpur successfully performed its first bone marrow transplant (BMT) on a 61 year old patient from Umariya, Madhya Pradesh. This was revealed by Dr A K Ganju, Hemato Oncologist while speaking at a press conference on Monday. On the occasion present were Dr Sunil Sahasrabuddhe, Facility Director, American Oncology Institute, Nagpur, Mahesh Nangia, Advisor on Board, Dr Naresh Jadhav, Dr Rani Lakhe, and Dr Vaibhav Sonwane. Dr Gunju said the patient came with complaints of suffering from severe body pain, tiredness and shortness of breath for two months in July 2017. Initial evaluation showed that the patient had anaemia with low platelet count. On further evaluation and bone marrow examination, the patient was found to have multiple Myeloma (A type of blood cancer affecting plasma cells present in the bone marrow causing anaemia, low platelets, bone weakness and high levels of abnormal protein in body).
This condition is generally seen in the elderly population and is not curable, he said. However, advances in medical management has made it possible to keep the disease at bay for prolonged periods of time. He explained that Myeloma is managed like a chronic disease with multiple lines of treatment. Autologous bone marrow transplant offers the best option to keep this disease under control. Before performing a transplant first the disease burden had to be brought down to minimum with chemotherapy. The patient was started on chemotherapy in July 2017 and continued with maintenance therapy. He was treated with multiple antimyeloma drugs and put into stringent remission.
Performing a BMT requires state-of-the-art facility and a highly qualified team of doctors and nurses. With the infrastructure and manpower in place at American Oncology Institute, Nagpur, the patient was taken up for transplant in July 2019. Dr Ganju, said that the patient underwent stem cell collection (apheresis) and was transferred inside the BMT unit. He received high dose chemotherapy and stem cells infusion. The patient was on a 24-hour intensive monitoring in the transplant unit. Thereafter, the patient recovered from his complications and was shifted out of the transplant unit, he said.
Dr A K Ganju thanked the team of doctors, medical officers and nurses who helped during the treatment process. Speaking on the occasion, Dr Sunil Sahasrabuddhe, said, “Traditionally, cancer has been considered a terminal ailment with uncertain prognosis and poor likelihood of survival. However, over the last few decades technology-driven improvements in diagnosis and treatment have significantly improved survival rates. With American university level treatment processes and standards, American Oncology Institute along with the expertise of Dr A K Ganju is providing better quality outcomes through a multi-disciplinary care programme backed by latest technology, centralised radiation treatment planning and international standard cancer treatment protocols”.